Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Trading Statement

22 Jul 2013 07:00

RNS Number : 7806J
HaiKe Chemical Group Ltd.
22 July 2013
 



 

HaiKe Chemical Group Ltd

 

Trading Update

 

HaiKe Chemical Group Limited ("HaiKe" or the "Company" or the "Group"), the AIM quoted (AIM: HAIK) petrochemical, speciality chemical and biochemical business based in China, today provides an update on trading ahead of its interim results for the six months period ended 30 June 2013.

 

The final results announced on 20 May 2013 noted that the Group performance has been impacted by lower utilisation rates and unfavourable feedstock prices in the refinery division and sluggish demand in the chemical business. In the first six months of 2013, these factors continued to have significant negative effects on the business, resulting in losses widening to approximately CNY327 million (H1 2012: CNY212.8 million) and further increases in bank borrowings. The banks continue to be supportive of the Group.

 

In the refinery business, the new pricing mechanism which has relaxed pricing controls over refined products in the domestic market has been implemented and we observed that most of the price adjustments were made on time. However, since the aim of the new pricing mechanism is to improve the transparency and predictability of the retail price of refined products and reduce the misalignment between the feedstock price and the retail price, the mechanism itself does not guarantee a positive average industry margin.

 

The performance of chemical products in H1 was mixed. Most products recorded an increase in sales volume as a result of more aggressive marketing efforts, but falling prices as a result of sluggish domestic demand have led to falling margins. Biochemicals delivered a comparable sales turnover but a decrease in profit as a result of a reduction in margins.

 

The difficult operating environment has impacted gross margins at Group level which fell further to approximately 0.3% in H1 2013 from 1.2% in H1 2012. Selling, general and administration expenses increased significantly due increased marketing spend. Balance sheet and cash flow positions have deteriorated as a result of increased losses. During the first half of this year, the Company's short-term debt increased by approximately CNY575 million to CNY6.6 billion as a result of an increase in bank borrowings. Negative operating cashflow before working capital changes was CNY102.1 million (2012: CNY28.3 million) and working capital has tightened.

 

The Board of HaiKe is disappointed by the performance of the business. The Company is considering its options given the difficult operating environment and will update shareholders when appropriate.

 

For further information please contact:

 

HaiKe Chemical Group

George Zeng, Chief Financial Officer

george@haikechemical.com

+86 138 2520 2570

Westhouse Securities

Martin Davison / Jonathan Haines

 

+44 (0) 20 7601 6100

Cardew Group

Shan Shan Willenbrock

Tom Horsman

haike@cardewgroup.com 

+44 (0) 20 7930 0777

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGZNFMLGFZM
Date   Source Headline
20th Apr 20099:13 amRNSRe Joint Venture
1st Apr 20097:00 amRNSChange of Adviser
16th Mar 20097:00 amRNSAppointment of Chief Financial Officer
12th Nov 20081:39 pmRNSTrading Statement Replacement
11th Nov 20088:44 amRNSTrading Statement
26th Sep 20087:00 amRNSProduction Update
17th Sep 20087:00 amRNSInterim Results
8th Sep 20088:45 amRNSMajor Contract & Project Comm
8th Sep 20087:00 amRNSNotice of Results
4th Sep 20087:00 amRNSCompany Update
23rd Jul 20082:01 pmRNSTrading Statement
11th Jul 200812:57 pmRNSDirector/PDMR Shareholding
11th Jul 200812:54 pmRNSDirector/PDMR Shareholding
10th Jul 20087:00 amRNSSpeciality chemical facility
20th Jun 200811:23 amRNSTrading Statement
20th Jun 20087:14 amRNSResult of AGM
20th Jun 20087:00 amRNS1st Quarter Results
11th Jun 20082:41 pmRNSNotice of Results
23rd May 200812:34 pmRNSAnnual Report and Accounts
30th Apr 20087:01 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSFinal Results
1st Apr 20087:00 amRNSNotice of Results
31st Mar 20089:27 amRNSStmnt re Share Price Movement
17th Dec 20074:38 pmRNSDirector/PDMR Shareholding
17th Dec 20079:38 amRNSDirector/PDMR Shareholding
12th Dec 200711:15 amRNSTrading Update
19th Nov 20077:00 amRNS3rd Quarter Results
2nd Nov 200710:24 amRNSTrading Statement
9th Oct 20071:00 pmRNSDirector/PDMR Shareholding
27th Sep 20072:24 pmRNSDirector/PDMR Shareholding
21st Sep 20079:43 amRNSTrading Statement
18th Sep 20079:00 amRNSTransfer of minority stake
10th Sep 20077:01 amRNSInterim Results
24th Aug 20071:53 pmRNSHolding(s) in Company
17th Aug 200711:24 amRNSAIM Rule 26
15th Aug 20071:33 pmRNSNotice of Results
20th Jun 200710:11 amRNSAGM Statement
1st Jun 200712:34 pmRNSDirector/PDMR Shareholding
30th May 20075:04 pmRNSDirector/PDMR Shareholding
24th May 20077:00 amRNS1st Quarter Results
22nd May 20077:01 amRNSShareholder Documentation
17th May 20078:43 amRNSNotice of Results
3rd Apr 20079:13 amRNSDirector/PDMR Shareholding
3rd Apr 20077:01 amRNSFinal Results
27th Mar 20073:12 pmRNSNotice of Results
15th Feb 20075:03 pmRNSHolding(s) in Company
14th Feb 20078:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.